YP
TEVA icon

Yellowstone Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Yellowstone Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$302K Buy
6,563
+1,064
+19% +$55.5K 0.11% 164
2016
Q2 		$276K Sell
5,499
-146
-3% -$7.77K 0.12% 142
2016
Q1 		$302K Buy
5,645
+1,209
+27% +$70.9K 0.13% 136
2015
Q4 		$291K Buy
+4,436
New +$274K 0.13% 136

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Yellowstone Partners's TEVA Position: Q3 2016 in Review

Yellowstone Partners increased its Teva Pharmaceuticals (TEVA) stake by 19% in Q3 2016, buying an estimated $55.5K and bringing the position to 6,563 shares worth $302K. The position accounts for 0.11% of the portfolio, ranked #164.

Yellowstone Partners first reported a position in TEVA in Q4 2015 and has held it in 4 quarters since. 795 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

  • Yellowstone Partners held 6,563 shares of Teva Pharmaceuticals worth $302K as of Q3 2016.
  • Yellowstone Partners bought 1,064 Teva Pharmaceuticals shares in Q3 2016, an estimated $55.5K.
  • Teva Pharmaceuticals made up 0.11% of Yellowstone Partners's portfolio in Q3 2016, its #164 holding.
  • Yellowstone Partners first reported a position in Teva Pharmaceuticals in Q4 2015 and has held it in 4 quarters since.
  • 795 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Yellowstone Partners's 13F filing for Q3 2016, filed 27 Oct 2016.